| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 5.61e-07 | 46 | 29 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 6.01e-07 | 12 | 29 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.04e-06 | 2 | 29 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.04e-06 | 2 | 29 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.11e-06 | 303 | 29 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 6.10e-06 | 3 | 29 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.54e-05 | 1160 | 29 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.62e-05 | 120 | 29 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 6.50e-05 | 54 | 29 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 8.64e-05 | 1356 | 29 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.32e-04 | 562 | 29 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.50e-04 | 188 | 29 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.11e-04 | 15 | 29 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.60e-04 | 86 | 29 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.20e-04 | 21 | 29 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.08e-03 | 140 | 29 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.31e-03 | 37 | 29 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.47e-03 | 156 | 29 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.69e-03 | 42 | 29 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.48e-03 | 51 | 29 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.48e-03 | 51 | 29 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.88e-03 | 55 | 29 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.42e-03 | 60 | 29 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 4.12e-03 | 66 | 29 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 4.12e-03 | 66 | 29 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | p53 binding | 5.57e-03 | 77 | 29 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 5.71e-03 | 78 | 29 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 6.60e-03 | 84 | 29 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 8.88e-03 | 98 | 29 | 2 | GO:0048306 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 9.59e-03 | 102 | 29 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 9.95e-03 | 104 | 29 | 2 | GO:0016407 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.14e-05 | 4 | 29 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.15e-05 | 1390 | 29 | 10 | GO:0045944 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 3.04e-05 | 445 | 29 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 3.78e-05 | 276 | 29 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 4.14e-05 | 48 | 29 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 4.75e-05 | 482 | 29 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | anterior head development | 5.32e-05 | 8 | 29 | 2 | GO:0097065 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 9.59e-05 | 336 | 29 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 9.83e-05 | 64 | 29 | 3 | GO:0010171 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.06e-04 | 343 | 29 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.12e-04 | 347 | 29 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.44e-04 | 192 | 29 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.53e-04 | 195 | 29 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.64e-04 | 76 | 29 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 2.26e-04 | 16 | 29 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 2.26e-04 | 16 | 29 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 2.55e-04 | 223 | 29 | 4 | GO:0007519 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.22e-04 | 237 | 29 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 3.38e-04 | 240 | 29 | 4 | GO:0060538 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.49e-04 | 242 | 29 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 4.74e-04 | 23 | 29 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 4.74e-04 | 23 | 29 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 4.74e-04 | 23 | 29 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | embryo development | 6.23e-04 | 1437 | 29 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 7.05e-04 | 28 | 29 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 7.57e-04 | 29 | 29 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 9.04e-04 | 136 | 29 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.01e-03 | 850 | 29 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.04e-03 | 1186 | 29 | 7 | GO:0007167 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.10e-03 | 35 | 29 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.10e-03 | 35 | 29 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 1.15e-03 | 148 | 29 | 3 | GO:0032963 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.23e-03 | 883 | 29 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.41e-03 | 906 | 29 | 6 | GO:0043009 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 1.51e-03 | 41 | 29 | 2 | GO:0060325 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.52e-03 | 615 | 29 | 5 | GO:0001501 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.60e-03 | 929 | 29 | 6 | GO:0009792 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.82e-03 | 377 | 29 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.84e-03 | 378 | 29 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.85e-03 | 379 | 29 | 4 | GO:0045229 | |
| GeneOntologyCellularComponent | collagen trimer | 1.29e-07 | 88 | 29 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.24e-07 | 12 | 29 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.24e-07 | 12 | 29 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.14e-06 | 21 | 29 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.34e-05 | 596 | 29 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.85e-05 | 5 | 29 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.31e-05 | 272 | 29 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 6.82e-05 | 1377 | 29 | 9 | GO:0140513 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.44e-04 | 13 | 29 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.38e-04 | 530 | 29 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 7.89e-04 | 30 | 29 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.08e-03 | 332 | 29 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.90e-03 | 656 | 29 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.93e-03 | 658 | 29 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | kinetochore | 1.98e-03 | 181 | 29 | 3 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.37e-03 | 193 | 29 | 3 | GO:0000779 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 6.45e-03 | 276 | 29 | 3 | GO:0000775 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 7.51e-03 | 94 | 29 | 2 | GO:0000123 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 7.82e-03 | 96 | 29 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | condensed chromosome | 8.64e-03 | 307 | 29 | 3 | GO:0000793 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 9.12e-03 | 104 | 29 | 2 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 9.98e-03 | 109 | 29 | 2 | GO:1902493 | |
| GeneOntologyCellularComponent | basement membrane | 1.24e-02 | 122 | 29 | 2 | GO:0005604 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 2.00e-07 | 30 | 10 | 4 | HP:0005743 | |
| HumanPheno | Juvenile aseptic necrosis | 8.91e-07 | 43 | 10 | 4 | HP:0100323 | |
| HumanPheno | Mitral valve prolapse | 1.73e-06 | 123 | 10 | 5 | HP:0001634 | |
| HumanPheno | Hypoplastic aortic arch | 1.96e-06 | 14 | 10 | 3 | HP:0012304 | |
| HumanPheno | Social and occupational deterioration | 2.45e-06 | 15 | 10 | 3 | HP:0007086 | |
| HumanPheno | Plantar crease between first and second toes | 3.47e-06 | 2 | 10 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 3.47e-06 | 2 | 10 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 3.47e-06 | 2 | 10 | 2 | HP:0001042 | |
| HumanPheno | Abnormal mitral valve morphology | 4.06e-06 | 146 | 10 | 5 | HP:0031477 | |
| HumanPheno | Abnormal sternum morphology | 5.42e-06 | 474 | 10 | 7 | HP:0000766 | |
| HumanPheno | Broad long bones | 5.81e-06 | 157 | 10 | 5 | HP:0005622 | |
| HumanPheno | Atypical scarring of skin | 8.07e-06 | 74 | 10 | 4 | HP:0000987 | |
| HumanPheno | Abnormal foramen magnum morphology | 9.45e-06 | 23 | 10 | 3 | HP:0002699 | |
| HumanPheno | Laryngeal cartilage malformation | 1.04e-05 | 3 | 10 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.04e-05 | 3 | 10 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.04e-05 | 3 | 10 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.04e-05 | 3 | 10 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.04e-05 | 3 | 10 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.04e-05 | 3 | 10 | 2 | HP:0005895 | |
| HumanPheno | Pectus excavatum | 1.05e-05 | 323 | 10 | 6 | HP:0000767 | |
| HumanPheno | Abnormality of the epiphysis of the femoral head | 1.28e-05 | 83 | 10 | 4 | HP:0010574 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 1.47e-05 | 86 | 10 | 4 | HP:0006499 | |
| HumanPheno | Flared metaphysis | 1.52e-05 | 191 | 10 | 5 | HP:0003015 | |
| HumanPheno | Deviation of the hallux | 1.61e-05 | 88 | 10 | 4 | HP:0010051 | |
| HumanPheno | Abnormal femoral head morphology | 1.93e-05 | 92 | 10 | 4 | HP:0003368 | |
| HumanPheno | Avascular necrosis | 1.93e-05 | 92 | 10 | 4 | HP:0010885 | |
| HumanPheno | Trichiasis | 2.08e-05 | 4 | 10 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.08e-05 | 4 | 10 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.08e-05 | 4 | 10 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.08e-05 | 4 | 10 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.08e-05 | 4 | 10 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.08e-05 | 4 | 10 | 2 | HP:0031207 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 2.10e-05 | 94 | 10 | 4 | HP:0006500 | |
| HumanPheno | Pes planus | 2.13e-05 | 365 | 10 | 6 | HP:0001763 | |
| HumanPheno | Upper extremity joint dislocation | 2.28e-05 | 96 | 10 | 4 | HP:0030310 | |
| HumanPheno | Hypoplastic iliac wing | 2.38e-05 | 31 | 10 | 3 | HP:0002866 | |
| HumanPheno | Joint subluxation | 2.38e-05 | 31 | 10 | 3 | HP:0032153 | |
| HumanPheno | Abnormal hallux morphology | 2.53e-05 | 212 | 10 | 5 | HP:0001844 | |
| HumanPheno | Scarring | 2.90e-05 | 102 | 10 | 4 | HP:0100699 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.46e-05 | 5 | 10 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 3.46e-05 | 5 | 10 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 3.46e-05 | 5 | 10 | 2 | HP:0030421 | |
| HumanPheno | Abnormal patella morphology | 3.77e-05 | 109 | 10 | 4 | HP:0003045 | |
| HumanPheno | Metaphyseal widening | 3.92e-05 | 232 | 10 | 5 | HP:0003016 | |
| HumanPheno | Nasogastric tube feeding in infancy | 4.09e-05 | 37 | 10 | 3 | HP:0011470 | |
| HumanPheno | Deviation of toes | 5.16e-05 | 118 | 10 | 4 | HP:0100498 | |
| HumanPheno | Large foramen magnum | 5.18e-05 | 6 | 10 | 2 | HP:0002700 | |
| HumanPheno | Abnormal mitral valve morphology | 6.43e-05 | 257 | 10 | 5 | HP:0001633 | |
| HumanPheno | Spinal cord compression | 6.92e-05 | 44 | 10 | 3 | HP:0002176 | |
| HumanPheno | Deviated nasal septum | 7.25e-05 | 7 | 10 | 2 | HP:0004411 | |
| HumanPheno | Broad phalanx of the toes | 8.44e-05 | 47 | 10 | 3 | HP:0010174 | |
| HumanPheno | Abnormal earlobe morphology | 9.27e-05 | 137 | 10 | 4 | HP:0000363 | |
| HumanPheno | Abnormal limb epiphysis morphology | 9.54e-05 | 138 | 10 | 4 | HP:0006505 | |
| HumanPheno | Arterial rupture | 9.65e-05 | 8 | 10 | 2 | HP:0025019 | |
| HumanPheno | Dental crowding | 1.13e-04 | 144 | 10 | 4 | HP:0000678 | |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 1.14e-04 | 52 | 10 | 3 | HP:0009834 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 1.21e-04 | 53 | 10 | 3 | HP:0009906 | |
| HumanPheno | Pilomatrixoma | 1.24e-04 | 9 | 10 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 1.24e-04 | 9 | 10 | 2 | HP:0002341 | |
| HumanPheno | Broad phalanx | 1.25e-04 | 148 | 10 | 4 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 1.25e-04 | 148 | 10 | 4 | HP:0009768 | |
| HumanPheno | Dislocated radial head | 1.28e-04 | 54 | 10 | 3 | HP:0003083 | |
| HumanPheno | Broad finger | 1.46e-04 | 154 | 10 | 4 | HP:0001500 | |
| HumanPheno | Abnormality of the radial head | 1.51e-04 | 57 | 10 | 3 | HP:0003995 | |
| HumanPheno | Frontal hirsutism | 1.55e-04 | 10 | 10 | 2 | HP:0011335 | |
| HumanPheno | Abnormal maxilla morphology | 1.62e-04 | 158 | 10 | 4 | HP:0000326 | |
| HumanPheno | Inguinal hernia | 1.63e-04 | 312 | 10 | 5 | HP:0000023 | |
| HumanPheno | High palate | 1.70e-04 | 794 | 10 | 7 | HP:0000218 | |
| HumanPheno | Lower extremity joint dislocation | 1.78e-04 | 318 | 10 | 5 | HP:0030311 | |
| HumanPheno | Abnormal subclavian artery morphology | 1.89e-04 | 11 | 10 | 2 | HP:0031251 | |
| HumanPheno | Abnormality of the humeroradial joint | 1.94e-04 | 62 | 10 | 3 | HP:0100744 | |
| HumanPheno | Hypoplastic ilia | 2.03e-04 | 63 | 10 | 3 | HP:0000946 | |
| HumanPheno | Joint hypermobility | 2.38e-04 | 557 | 10 | 6 | HP:0001382 | |
| HumanPheno | Abnormal iliac wing morphology | 2.55e-04 | 68 | 10 | 3 | HP:0011867 | |
| HumanPheno | Abnormal metaphysis morphology | 2.59e-04 | 344 | 10 | 5 | HP:0000944 | |
| HumanPheno | Facial grimacing | 2.67e-04 | 13 | 10 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 2.67e-04 | 13 | 10 | 2 | HP:0010562 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 2.81e-04 | 350 | 10 | 5 | HP:0006705 | |
| HumanPheno | Patellar dislocation | 2.90e-04 | 71 | 10 | 3 | HP:0002999 | |
| HumanPheno | Overlapping toe | 3.03e-04 | 72 | 10 | 3 | HP:0001845 | |
| HumanPheno | Duplication of phalanx of hallux | 3.12e-04 | 14 | 10 | 2 | HP:0010066 | |
| HumanPheno | Parietal foramina | 3.12e-04 | 14 | 10 | 2 | HP:0002697 | |
| HumanPheno | Neonatal short-limb short stature | 3.12e-04 | 14 | 10 | 2 | HP:0008921 | |
| HumanPheno | Soft, doughy skin | 3.12e-04 | 14 | 10 | 2 | HP:0001027 | |
| HumanPheno | Abnormal heart valve morphology | 3.22e-04 | 588 | 10 | 6 | HP:0001654 | |
| HumanPheno | Abnormal aortic morphology | 3.34e-04 | 363 | 10 | 5 | HP:0030963 | |
| HumanPheno | Abnormal knee morphology | 3.38e-04 | 364 | 10 | 5 | HP:0034669 | |
| HumanPheno | Broad hallux | 3.55e-04 | 76 | 10 | 3 | HP:0010055 | |
| HumanPheno | Abnormality of dental structure | 3.56e-04 | 368 | 10 | 5 | HP:0011061 | |
| HumanPheno | Duplication of phalanx of toe | 3.59e-04 | 15 | 10 | 2 | HP:0010181 | |
| HumanPheno | Retrognathia | 3.89e-04 | 375 | 10 | 5 | HP:0000278 | |
| HumanPheno | Epicanthus | 4.10e-04 | 614 | 10 | 6 | HP:0000286 | |
| HumanPheno | Abnormal femoral neck/head morphology | 4.10e-04 | 201 | 10 | 4 | HP:0003366 | |
| HumanPheno | Abnormal bladder morphology | 4.10e-04 | 201 | 10 | 4 | HP:0025487 | |
| HumanPheno | Square face | 4.10e-04 | 16 | 10 | 2 | HP:0000321 | |
| HumanPheno | Persistent left superior vena cava | 4.61e-04 | 83 | 10 | 3 | HP:0005301 | |
| HumanPheno | Premature thelarche | 4.64e-04 | 17 | 10 | 2 | HP:0010314 | |
| HumanPheno | Joint dislocation | 4.68e-04 | 390 | 10 | 5 | HP:0001373 | |
| HumanPheno | Elbow dislocation | 4.78e-04 | 84 | 10 | 3 | HP:0003042 | |
| HumanPheno | Abnormal superior vena cava morphology | 4.94e-04 | 85 | 10 | 3 | HP:0025575 | |
| MousePheno | nasal bone hypoplasia | 1.84e-05 | 4 | 25 | 2 | MP:0000103 | |
| MousePheno | embryonic growth arrest | 2.62e-05 | 346 | 25 | 6 | MP:0001730 | |
| MousePheno | increased megakaryocyte cell number | 6.82e-05 | 45 | 25 | 3 | MP:0008254 | |
| MousePheno | hemorrhage | 1.20e-04 | 664 | 25 | 7 | MP:0001914 | |
| MousePheno | kinked neural tube | 1.39e-04 | 57 | 25 | 3 | MP:0003400 | |
| MousePheno | maxilla hypoplasia | 2.00e-04 | 12 | 25 | 2 | MP:0000457 | |
| MousePheno | abnormal chorionic plate morphology | 3.18e-04 | 15 | 25 | 2 | MP:0004560 | |
| MousePheno | abnormal post-tetanic potentiation | 4.62e-04 | 18 | 25 | 2 | MP:0002921 | |
| MousePheno | abnormal megakaryocyte morphology | 4.69e-04 | 86 | 25 | 3 | MP:0002417 | |
| MousePheno | abnormal embryonic tissue morphology | 5.08e-04 | 1116 | 25 | 8 | MP:0002085 | |
| MousePheno | abnormal blood circulation | 5.29e-04 | 845 | 25 | 7 | MP:0002128 | |
| MousePheno | thin ventricle myocardium compact layer | 5.72e-04 | 20 | 25 | 2 | MP:0010556 | |
| MousePheno | abnormal joint morphology | 5.98e-04 | 397 | 25 | 5 | MP:0002932 | |
| Domain | Collagen | 1.89e-07 | 85 | 29 | 5 | PF01391 | |
| Domain | Collagen | 1.89e-07 | 85 | 29 | 5 | IPR008160 | |
| Domain | NC1_FIB | 5.51e-07 | 11 | 29 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 5.51e-07 | 11 | 29 | 3 | IPR000885 | |
| Domain | Fib_collagen_C | 5.51e-07 | 11 | 29 | 3 | PD002078 | |
| Domain | COLFI | 5.51e-07 | 11 | 29 | 3 | SM00038 | |
| Domain | COLFI | 5.51e-07 | 11 | 29 | 3 | PF01410 | |
| Domain | - | 2.33e-06 | 2 | 29 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.33e-06 | 2 | 29 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.33e-06 | 2 | 29 | 2 | PS50134 | |
| Domain | BCL9_beta-catenin-bd_dom | 2.33e-06 | 2 | 29 | 2 | IPR024670 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.33e-06 | 2 | 29 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.33e-06 | 2 | 29 | 2 | PF08214 | |
| Domain | KIX | 2.33e-06 | 2 | 29 | 2 | PS50952 | |
| Domain | BCL9 | 2.33e-06 | 2 | 29 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 2.33e-06 | 2 | 29 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.33e-06 | 2 | 29 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.33e-06 | 2 | 29 | 2 | IPR013178 | |
| Domain | DUF902 | 2.33e-06 | 2 | 29 | 2 | PF06001 | |
| Domain | - | 2.33e-06 | 2 | 29 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.33e-06 | 2 | 29 | 2 | IPR010303 | |
| Domain | KAT11 | 2.33e-06 | 2 | 29 | 2 | SM01250 | |
| Domain | - | 2.33e-06 | 2 | 29 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 2.33e-06 | 2 | 29 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.33e-06 | 2 | 29 | 2 | IPR003101 | |
| Domain | Creb_binding | 2.33e-06 | 2 | 29 | 2 | PF09030 | |
| Domain | KIX | 2.33e-06 | 2 | 29 | 2 | PF02172 | |
| Domain | Bcl-9 | 2.33e-06 | 2 | 29 | 2 | IPR015668 | |
| Domain | CBP_P300_HAT | 2.33e-06 | 2 | 29 | 2 | PS51727 | |
| Domain | Bromodomain_CS | 8.54e-06 | 26 | 29 | 3 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 2.52e-05 | 37 | 29 | 3 | PS00633 | |
| Domain | Bromodomain | 2.74e-05 | 38 | 29 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.45e-05 | 41 | 29 | 3 | PS50014 | |
| Domain | Nuc_rcpt_coact | 3.48e-05 | 6 | 29 | 2 | IPR009110 | |
| Domain | BROMO | 3.71e-05 | 42 | 29 | 3 | SM00297 | |
| Domain | Bromodomain | 3.71e-05 | 42 | 29 | 3 | IPR001487 | |
| Domain | - | 3.71e-05 | 42 | 29 | 3 | 1.20.920.10 | |
| Domain | ZF_ZZ_2 | 3.51e-04 | 18 | 29 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.51e-04 | 18 | 29 | 2 | PS01357 | |
| Domain | ZZ | 3.51e-04 | 18 | 29 | 2 | PF00569 | |
| Domain | Znf_ZZ | 3.92e-04 | 19 | 29 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.92e-04 | 19 | 29 | 2 | SM00291 | |
| Domain | TSPN | 5.77e-04 | 23 | 29 | 2 | SM00210 | |
| Domain | Laminin_G | 3.65e-03 | 58 | 29 | 2 | IPR001791 | |
| Domain | - | 9.51e-03 | 95 | 29 | 2 | 2.60.120.200 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.56e-07 | 41 | 21 | 4 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.75e-07 | 44 | 21 | 4 | M27812 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.02e-06 | 53 | 21 | 4 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.80e-06 | 61 | 21 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.18e-06 | 64 | 21 | 4 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.62e-06 | 67 | 21 | 4 | M26999 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.72e-06 | 19 | 21 | 3 | MM15512 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.35e-06 | 76 | 21 | 4 | MM14573 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 7.25e-06 | 26 | 21 | 3 | MM14793 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.56e-06 | 90 | 21 | 4 | M631 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 8.94e-06 | 91 | 21 | 4 | M27101 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.13e-05 | 30 | 21 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.13e-05 | 30 | 21 | 3 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.37e-05 | 32 | 21 | 3 | MM14924 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.66e-05 | 34 | 21 | 3 | M39771 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.11e-05 | 5 | 21 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 2.11e-05 | 5 | 21 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 2.11e-05 | 5 | 21 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 2.11e-05 | 5 | 21 | 2 | M48023 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.18e-05 | 114 | 21 | 4 | MM14571 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.93e-05 | 41 | 21 | 3 | M27778 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.16e-05 | 6 | 21 | 2 | M22062 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.15e-05 | 46 | 21 | 3 | M198 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.42e-05 | 7 | 21 | 2 | MM1573 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.43e-05 | 47 | 21 | 3 | MM14925 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.89e-05 | 140 | 21 | 4 | M587 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.34e-05 | 50 | 21 | 3 | MM14796 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.89e-05 | 8 | 21 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 5.89e-05 | 8 | 21 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 5.89e-05 | 8 | 21 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 5.89e-05 | 8 | 21 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 7.56e-05 | 9 | 21 | 2 | M47451 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.78e-05 | 59 | 21 | 3 | M27218 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 9.44e-05 | 10 | 21 | 2 | M27945 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.70e-05 | 61 | 21 | 3 | M27103 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.15e-04 | 11 | 21 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.15e-04 | 11 | 21 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.15e-04 | 11 | 21 | 2 | M26924 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.23e-04 | 66 | 21 | 3 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.28e-04 | 67 | 21 | 3 | MM15345 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.38e-04 | 12 | 21 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.38e-04 | 12 | 21 | 2 | M27765 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 1.40e-04 | 69 | 21 | 3 | M48052 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.73e-04 | 74 | 21 | 3 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.87e-04 | 76 | 21 | 3 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.87e-04 | 76 | 21 | 3 | MM14867 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.90e-04 | 14 | 21 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.09e-04 | 79 | 21 | 3 | M27643 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.19e-04 | 15 | 21 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.19e-04 | 15 | 21 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M953 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.34e-04 | 82 | 21 | 3 | M2 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.50e-04 | 16 | 21 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.50e-04 | 16 | 21 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.50e-04 | 16 | 21 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.50e-04 | 16 | 21 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.50e-04 | 16 | 21 | 2 | M27940 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.51e-04 | 84 | 21 | 3 | M1008 | |
| Pathway | PID_CMYB_PATHWAY | 2.51e-04 | 84 | 21 | 3 | M195 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.51e-04 | 84 | 21 | 3 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.60e-04 | 85 | 21 | 3 | M16441 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 2.69e-04 | 86 | 21 | 3 | M39375 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.84e-04 | 17 | 21 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.84e-04 | 17 | 21 | 2 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.19e-04 | 18 | 21 | 2 | M26942 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.49e-04 | 233 | 21 | 4 | M27099 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 3.56e-04 | 19 | 21 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 3.56e-04 | 19 | 21 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.95e-04 | 20 | 21 | 2 | M27881 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.95e-04 | 20 | 21 | 2 | MM15061 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.96e-04 | 98 | 21 | 3 | M48247 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 4.36e-04 | 21 | 21 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 4.36e-04 | 21 | 21 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 4.80e-04 | 22 | 21 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.80e-04 | 22 | 21 | 2 | MM1370 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.13e-04 | 258 | 21 | 4 | MM14572 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 5.25e-04 | 23 | 21 | 2 | M2821 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.55e-04 | 110 | 21 | 3 | M48259 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.72e-04 | 24 | 21 | 2 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.21e-04 | 25 | 21 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 6.72e-04 | 26 | 21 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 6.72e-04 | 26 | 21 | 2 | M32 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 6.81e-04 | 118 | 21 | 3 | M27316 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 7.15e-04 | 120 | 21 | 3 | M48233 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 7.25e-04 | 27 | 21 | 2 | M27217 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 7.81e-04 | 28 | 21 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 8.97e-04 | 30 | 21 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 8.97e-04 | 30 | 21 | 2 | M936 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.04e-04 | 300 | 21 | 4 | M610 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.02e-03 | 32 | 21 | 2 | M39521 | |
| Pathway | PID_HIF2PATHWAY | 1.15e-03 | 34 | 21 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.15e-03 | 34 | 21 | 2 | MM15531 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.22e-03 | 35 | 21 | 2 | M48246 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.29e-03 | 330 | 21 | 4 | M7847 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.29e-03 | 36 | 21 | 2 | M633 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.36e-03 | 37 | 21 | 2 | M27797 | |
| Pathway | PID_FRA_PATHWAY | 1.36e-03 | 37 | 21 | 2 | M65 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.44e-03 | 38 | 21 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.44e-03 | 38 | 21 | 2 | M27255 | |
| Pubmed | 3.44e-09 | 152 | 30 | 6 | 38360978 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.80e-09 | 457 | 30 | 8 | 32344865 | |
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 12732631 | ||
| Pubmed | BCL9L DIDO1 PBRM1 SMG7 BCL9 SSBP3 SS18 CREBBP WDR33 EP300 SCAF4 | 1.44e-08 | 1429 | 30 | 11 | 35140242 | |
| Pubmed | 1.58e-08 | 549 | 30 | 8 | 38280479 | ||
| Pubmed | 3.13e-08 | 220 | 30 | 6 | 24550385 | ||
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 15872058 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 8900172 | ||
| Pubmed | 9.54e-08 | 453 | 30 | 7 | 29656893 | ||
| Pubmed | 1.21e-07 | 1014 | 30 | 9 | 32416067 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.08e-07 | 154 | 30 | 5 | 16055720 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 2.09e-07 | 14 | 30 | 3 | 17641689 | |
| Pubmed | 2.47e-07 | 1103 | 30 | 9 | 34189442 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.02e-07 | 807 | 30 | 8 | 22681889 | |
| Pubmed | 3.12e-07 | 66 | 30 | 4 | 23275444 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.51e-07 | 180 | 30 | 5 | 35198878 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 7.19e-07 | 2 | 30 | 2 | 34845315 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19729597 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15860545 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 7.19e-07 | 2 | 30 | 2 | 24551300 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33911074 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9018065 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24648406 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30135524 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 7.19e-07 | 2 | 30 | 2 | 16596650 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8020944 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 7.19e-07 | 2 | 30 | 2 | 29217654 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20717166 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10049825 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 38811552 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 7.19e-07 | 2 | 30 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 7.19e-07 | 2 | 30 | 2 | 29170789 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25893291 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11559821 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 7.19e-07 | 2 | 30 | 2 | 12646247 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15371335 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32576962 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19822209 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24522976 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 7.19e-07 | 2 | 30 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 7.19e-07 | 2 | 30 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 7.19e-07 | 2 | 30 | 2 | 34813504 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 7.19e-07 | 2 | 30 | 2 | 12696060 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11030627 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 7.19e-07 | 2 | 30 | 2 | 36109165 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24639469 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 37816914 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 7.19e-07 | 2 | 30 | 2 | 11438528 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10918613 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31182547 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35502657 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30635043 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 7.19e-07 | 2 | 30 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 7.19e-07 | 2 | 30 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 7.19e-07 | 2 | 30 | 2 | 27881443 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19272189 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10610021 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20682801 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 7.19e-07 | 2 | 30 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 7.19e-07 | 2 | 30 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 7.19e-07 | 2 | 30 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 7.19e-07 | 2 | 30 | 2 | 32690000 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9733868 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30953353 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21803292 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33767438 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28612031 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9811832 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 7.19e-07 | 2 | 30 | 2 | 33063428 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34506759 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22177454 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 7.19e-07 | 2 | 30 | 2 | 39266679 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22303793 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 7.19e-07 | 2 | 30 | 2 | 34019788 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 9.09e-07 | 934 | 30 | 8 | 33916271 | |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 1.01e-06 | 23 | 30 | 3 | 10235267 | |
| Pubmed | 1.16e-06 | 24 | 30 | 3 | 25344368 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.21e-06 | 220 | 30 | 5 | 35785414 | |
| Pubmed | 1.32e-06 | 25 | 30 | 3 | 19180518 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 2.16e-06 | 3 | 30 | 2 | 14716005 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 2.16e-06 | 3 | 30 | 2 | 21967847 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 2.16e-06 | 3 | 30 | 2 | 19252086 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23546968 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27903646 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 12748286 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 17024418 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10075656 | ||
| Interaction | SP7 interactions | 2.76e-10 | 304 | 29 | 9 | int:SP7 | |
| Interaction | PAX8 interactions | 1.04e-08 | 111 | 29 | 6 | int:PAX8 | |
| Interaction | NUP35 interactions | 1.05e-07 | 424 | 29 | 8 | int:NUP35 | |
| Interaction | PPIA interactions | 2.45e-07 | 888 | 29 | 10 | int:PPIA | |
| Interaction | SS18L1 interactions | 2.66e-07 | 98 | 29 | 5 | int:SS18L1 | |
| Interaction | GATA2 interactions | 3.38e-07 | 199 | 29 | 6 | int:GATA2 | |
| Interaction | SMARCC2 interactions | 5.34e-07 | 353 | 29 | 7 | int:SMARCC2 | |
| Interaction | CPSF6 interactions | 5.41e-07 | 526 | 29 | 8 | int:CPSF6 | |
| Interaction | TBXT interactions | 6.16e-07 | 116 | 29 | 5 | int:TBXT | |
| Interaction | ORC6 interactions | 7.00e-07 | 49 | 29 | 4 | int:ORC6 | |
| Interaction | FUS interactions | 7.23e-07 | 757 | 29 | 9 | int:FUS | |
| Interaction | TLE3 interactions | 8.15e-07 | 376 | 29 | 7 | int:TLE3 | |
| Interaction | PAX7 interactions | 8.58e-07 | 124 | 29 | 5 | int:PAX7 | |
| Interaction | EYA4 interactions | 1.09e-06 | 243 | 29 | 6 | int:EYA4 | |
| Interaction | LHX6 interactions | 1.39e-06 | 58 | 29 | 4 | int:LHX6 | |
| Interaction | SSBP4 interactions | 1.49e-06 | 59 | 29 | 4 | int:SSBP4 | |
| Interaction | MDC1 interactions | 1.55e-06 | 414 | 29 | 7 | int:MDC1 | |
| Interaction | GCM1 interactions | 2.64e-06 | 68 | 29 | 4 | int:GCM1 | |
| Interaction | PRNP interactions | 2.77e-06 | 1158 | 29 | 10 | int:PRNP | |
| Interaction | ETV4 interactions | 2.80e-06 | 69 | 29 | 4 | int:ETV4 | |
| Interaction | MAML1 interactions | 3.51e-06 | 73 | 29 | 4 | int:MAML1 | |
| Interaction | FOS interactions | 4.62e-06 | 312 | 29 | 6 | int:FOS | |
| Interaction | TLX1 interactions | 4.68e-06 | 175 | 29 | 5 | int:TLX1 | |
| Interaction | LHX2 interactions | 5.82e-06 | 183 | 29 | 5 | int:LHX2 | |
| Interaction | IRF1 interactions | 5.87e-06 | 83 | 29 | 4 | int:IRF1 | |
| Interaction | IRF4 interactions | 6.46e-06 | 85 | 29 | 4 | int:IRF4 | |
| Interaction | GATA3 interactions | 6.46e-06 | 187 | 29 | 5 | int:GATA3 | |
| Interaction | AR interactions | 6.71e-06 | 992 | 29 | 9 | int:AR | |
| Interaction | BCL9 interactions | 6.77e-06 | 86 | 29 | 4 | int:BCL9 | |
| Interaction | GSC interactions | 7.09e-06 | 87 | 29 | 4 | int:GSC | |
| Interaction | MYOD1 interactions | 7.73e-06 | 194 | 29 | 5 | int:MYOD1 | |
| Interaction | KLF5 interactions | 7.92e-06 | 195 | 29 | 5 | int:KLF5 | |
| Interaction | TP53BP1 interactions | 8.19e-06 | 533 | 29 | 7 | int:TP53BP1 | |
| Interaction | SMARCA2 interactions | 8.34e-06 | 346 | 29 | 6 | int:SMARCA2 | |
| Interaction | PYGO1 interactions | 8.57e-06 | 28 | 29 | 3 | int:PYGO1 | |
| Interaction | FEV interactions | 9.63e-06 | 203 | 29 | 5 | int:FEV | |
| Interaction | SOX9 interactions | 1.09e-05 | 97 | 29 | 4 | int:SOX9 | |
| Interaction | PDGFA interactions | 1.29e-05 | 32 | 29 | 3 | int:PDGFA | |
| Interaction | ACTB interactions | 1.36e-05 | 1083 | 29 | 9 | int:ACTB | |
| Interaction | YAP1 interactions | 1.49e-05 | 1095 | 29 | 9 | int:YAP1 | |
| Interaction | SSBP2 interactions | 1.49e-05 | 105 | 29 | 4 | int:SSBP2 | |
| Interaction | SMARCC1 interactions | 1.51e-05 | 384 | 29 | 6 | int:SMARCC1 | |
| Interaction | ERG interactions | 1.52e-05 | 223 | 29 | 5 | int:ERG | |
| Interaction | WBP4 interactions | 1.73e-05 | 109 | 29 | 4 | int:WBP4 | |
| Interaction | BMAL1 interactions | 1.86e-05 | 111 | 29 | 4 | int:BMAL1 | |
| Interaction | THRA interactions | 1.86e-05 | 111 | 29 | 4 | int:THRA | |
| Interaction | TBR1 interactions | 2.00e-05 | 113 | 29 | 4 | int:TBR1 | |
| Interaction | H2BC3 interactions | 2.07e-05 | 406 | 29 | 6 | int:H2BC3 | |
| Interaction | LDB1 interactions | 2.14e-05 | 115 | 29 | 4 | int:LDB1 | |
| Interaction | WWOX interactions | 2.34e-05 | 627 | 29 | 7 | int:WWOX | |
| Interaction | DDIT3 interactions | 2.53e-05 | 120 | 29 | 4 | int:DDIT3 | |
| Interaction | WWTR1 interactions | 2.57e-05 | 422 | 29 | 6 | int:WWTR1 | |
| Interaction | TFF1 interactions | 2.75e-05 | 41 | 29 | 3 | int:TFF1 | |
| Interaction | ISL1 interactions | 2.75e-05 | 41 | 29 | 3 | int:ISL1 | |
| Interaction | ISL2 interactions | 2.75e-05 | 41 | 29 | 3 | int:ISL2 | |
| Interaction | PROX1 interactions | 2.75e-05 | 41 | 29 | 3 | int:PROX1 | |
| Interaction | CRX interactions | 2.84e-05 | 254 | 29 | 5 | int:CRX | |
| Interaction | LGR6 interactions | 2.99e-05 | 6 | 29 | 2 | int:LGR6 | |
| Interaction | PAX9 interactions | 3.46e-05 | 130 | 29 | 4 | int:PAX9 | |
| Interaction | H3-4 interactions | 3.59e-05 | 448 | 29 | 6 | int:H3-4 | |
| Interaction | CEBPA interactions | 4.13e-05 | 1245 | 29 | 9 | int:CEBPA | |
| Interaction | ARID1A interactions | 4.21e-05 | 276 | 29 | 5 | int:ARID1A | |
| Interaction | SMARCA4 interactions | 4.26e-05 | 462 | 29 | 6 | int:SMARCA4 | |
| Interaction | PYGO2 interactions | 4.44e-05 | 48 | 29 | 3 | int:PYGO2 | |
| Interaction | BCL9L interactions | 4.44e-05 | 48 | 29 | 3 | int:BCL9L | |
| Interaction | H2BC21 interactions | 4.57e-05 | 696 | 29 | 7 | int:H2BC21 | |
| Interaction | SOX15 interactions | 4.76e-05 | 141 | 29 | 4 | int:SOX15 | |
| Interaction | NR3C1 interactions | 5.01e-05 | 974 | 29 | 8 | int:NR3C1 | |
| Interaction | NAA40 interactions | 5.15e-05 | 978 | 29 | 8 | int:NAA40 | |
| Interaction | CELF1 interactions | 5.16e-05 | 288 | 29 | 5 | int:CELF1 | |
| Interaction | NANOG interactions | 5.34e-05 | 481 | 29 | 6 | int:NANOG | |
| Interaction | MECP2 interactions | 5.35e-05 | 1287 | 29 | 9 | int:MECP2 | |
| Interaction | SNRPA interactions | 5.40e-05 | 482 | 29 | 6 | int:SNRPA | |
| Interaction | TLX3 interactions | 5.42e-05 | 291 | 29 | 5 | int:TLX3 | |
| Interaction | HES6 interactions | 5.65e-05 | 52 | 29 | 3 | int:HES6 | |
| Interaction | LHX8 interactions | 5.98e-05 | 53 | 29 | 3 | int:LHX8 | |
| Interaction | ELF3 interactions | 6.32e-05 | 54 | 29 | 3 | int:ELF3 | |
| Interaction | CIITA interactions | 6.68e-05 | 55 | 29 | 3 | int:CIITA | |
| Interaction | PPARG interactions | 6.98e-05 | 307 | 29 | 5 | int:PPARG | |
| Interaction | LDB2 interactions | 7.05e-05 | 56 | 29 | 3 | int:LDB2 | |
| Interaction | HOXB3 interactions | 7.15e-05 | 9 | 29 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 7.15e-05 | 9 | 29 | 2 | int:ARGFX | |
| Interaction | MED21 interactions | 7.60e-05 | 159 | 29 | 4 | int:MED21 | |
| Interaction | YLPM1 interactions | 7.78e-05 | 160 | 29 | 4 | int:YLPM1 | |
| Interaction | COL5A3 interactions | 8.93e-05 | 10 | 29 | 2 | int:COL5A3 | |
| Interaction | LHX4 interactions | 8.98e-05 | 166 | 29 | 4 | int:LHX4 | |
| Interaction | RUNX1 interactions | 9.01e-05 | 324 | 29 | 5 | int:RUNX1 | |
| Interaction | C1QTNF2 interactions | 9.57e-05 | 62 | 29 | 3 | int:C1QTNF2 | |
| Interaction | FMR1 interactions | 9.71e-05 | 536 | 29 | 6 | int:FMR1 | |
| Interaction | DTX2 interactions | 9.82e-05 | 330 | 29 | 5 | int:DTX2 | |
| Interaction | EGR2 interactions | 1.01e-04 | 171 | 29 | 4 | int:EGR2 | |
| Interaction | EPAS1 interactions | 1.05e-04 | 173 | 29 | 4 | int:EPAS1 | |
| Interaction | SPARC interactions | 1.10e-04 | 65 | 29 | 3 | int:SPARC | |
| Interaction | TEAD1 interactions | 1.13e-04 | 176 | 29 | 4 | int:TEAD1 | |
| Interaction | ARID1B interactions | 1.15e-04 | 177 | 29 | 4 | int:ARID1B | |
| Interaction | MMP9 interactions | 1.21e-04 | 67 | 29 | 3 | int:MMP9 | |
| Interaction | CPAP interactions | 1.28e-04 | 182 | 29 | 4 | int:CPAP | |
| Interaction | CEBPB interactions | 1.30e-04 | 1443 | 29 | 9 | int:CEBPB | |
| Interaction | ALG13 interactions | 1.31e-04 | 183 | 29 | 4 | int:ALG13 | |
| Interaction | LHX3 interactions | 1.36e-04 | 185 | 29 | 4 | int:LHX3 | |
| GeneFamily | Collagens | 1.09e-07 | 46 | 18 | 4 | 490 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.26e-04 | 17 | 18 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.42e-04 | 18 | 18 | 2 | 91 | |
| GeneFamily | RNA binding motif containing | 1.87e-02 | 213 | 18 | 2 | 725 | |
| GeneFamily | WD repeat domain containing | 2.75e-02 | 262 | 18 | 2 | 362 | |
| Coexpression | NABA_COLLAGENS | 1.67e-07 | 43 | 30 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.83e-07 | 44 | 30 | 4 | M3005 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.55e-06 | 323 | 30 | 6 | M9150 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 3.00e-06 | 200 | 30 | 5 | M4352 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 1.11e-05 | 988 | 30 | 8 | M6616 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.28e-05 | 467 | 30 | 6 | M1347 | |
| Coexpression | WANG_CLIM2_TARGETS_UP | 1.29e-05 | 270 | 30 | 5 | M10334 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.52e-05 | 734 | 30 | 7 | M3835 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.57e-05 | 484 | 30 | 6 | MM999 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 5.63e-05 | 65 | 30 | 3 | M39309 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN | 7.72e-05 | 200 | 30 | 4 | M4108 | |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 1.25e-04 | 85 | 30 | 3 | M17423 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.57e-04 | 457 | 30 | 5 | M1613 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.70e-04 | 17 | 30 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.70e-04 | 17 | 30 | 2 | MM1297 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.79e-04 | 470 | 30 | 5 | MM1053 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 2.14e-04 | 19 | 30 | 2 | M15125 | |
| Coexpression | NABA_CORE_MATRISOME | 2.44e-04 | 270 | 30 | 4 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.62e-04 | 275 | 30 | 4 | M5884 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 2.88e-04 | 22 | 30 | 2 | M40074 | |
| Coexpression | IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN | 3.74e-04 | 25 | 30 | 2 | M16374 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 3.84e-04 | 555 | 30 | 5 | M2343 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.00e-04 | 126 | 30 | 3 | M39132 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 4.19e-04 | 128 | 30 | 3 | M6083 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 5.04e-04 | 29 | 30 | 2 | MM17055 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 6.69e-07 | 790 | 29 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.08e-06 | 413 | 29 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.17e-06 | 259 | 29 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_200 | 1.54e-06 | 17 | 29 | 3 | gudmap_developingGonad_e16.5_epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_200 | 5.16e-06 | 25 | 29 | 3 | gudmap_developingGonad_e14.5_ epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 8.40e-06 | 801 | 29 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 8.79e-06 | 806 | 29 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.37e-05 | 230 | 29 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.54e-05 | 406 | 29 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 2.19e-05 | 40 | 29 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.35e-05 | 277 | 29 | 5 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 4.30e-05 | 50 | 29 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 7.35e-05 | 166 | 29 | 4 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 7.52e-05 | 167 | 29 | 4 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 7.62e-05 | 795 | 29 | 7 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 7.74e-05 | 797 | 29 | 7 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.80e-05 | 331 | 29 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 7.86e-05 | 799 | 29 | 7 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_100 | 8.05e-05 | 10 | 29 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 8.18e-05 | 804 | 29 | 7 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.14e-04 | 186 | 29 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.42e-04 | 197 | 29 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.82e-04 | 210 | 29 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 2.30e-04 | 417 | 29 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_100 | 2.72e-04 | 18 | 29 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.48e-04 | 249 | 29 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 4.91e-04 | 492 | 29 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 5.30e-04 | 25 | 29 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 6.99e-04 | 815 | 29 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.17e-04 | 31 | 29 | 2 | gudmap_developingGonad_e14.5_ testes_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 8.31e-04 | 136 | 29 | 3 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.24e-04 | 323 | 29 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.05e-03 | 334 | 29 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-03 | 150 | 29 | 3 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.12e-03 | 151 | 29 | 3 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.24e-03 | 156 | 29 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 1.50e-03 | 42 | 29 | 2 | gudmap_developingGonad_e11.5_testes_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.55e-03 | 169 | 29 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.72e-03 | 175 | 29 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.80e-03 | 978 | 29 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 1.80e-03 | 46 | 29 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.94e-03 | 395 | 29 | 4 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.94e-03 | 993 | 29 | 6 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 2.09e-03 | 403 | 29 | 4 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 2.10e-03 | 404 | 29 | 4 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 2.20e-03 | 409 | 29 | 4 | gudmap_developingGonad_e12.5_ovary_500 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-07 | 196 | 30 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.99e-06 | 178 | 30 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.13e-06 | 186 | 30 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-06 | 189 | 30 | 4 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-06 | 189 | 30 | 4 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.91e-06 | 191 | 30 | 4 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 194 | 30 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 198 | 30 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 198 | 30 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-04 | 151 | 30 | 3 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 1.64e-04 | 159 | 30 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-04 | 169 | 30 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 170 | 30 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.11e-04 | 32 | 30 | 2 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.11e-04 | 32 | 30 | 2 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.14e-04 | 174 | 30 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 175 | 30 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 177 | 30 | 3 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 179 | 30 | 3 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-04 | 181 | 30 | 3 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-04 | 181 | 30 | 3 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-04 | 183 | 30 | 3 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-04 | 183 | 30 | 3 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 185 | 30 | 3 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.56e-04 | 185 | 30 | 3 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 2.68e-04 | 188 | 30 | 3 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.68e-04 | 188 | 30 | 3 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.68e-04 | 188 | 30 | 3 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-04 | 189 | 30 | 3 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 191 | 30 | 3 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.81e-04 | 191 | 30 | 3 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 191 | 30 | 3 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-04 | 192 | 30 | 3 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 192 | 30 | 3 | ced2fdbcb181ac250ff50cd4d5d886e568924203 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 192 | 30 | 3 | 19b8675ed8a99bd3d08ad043e4ec9f006426c22f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-04 | 192 | 30 | 3 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 193 | 30 | 3 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.94e-04 | 194 | 30 | 3 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.94e-04 | 194 | 30 | 3 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 2.99e-04 | 195 | 30 | 3 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 2.99e-04 | 195 | 30 | 3 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 195 | 30 | 3 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-04 | 196 | 30 | 3 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.03e-04 | 196 | 30 | 3 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-04 | 197 | 30 | 3 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 197 | 30 | 3 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 198 | 30 | 3 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 198 | 30 | 3 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-04 | 198 | 30 | 3 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 198 | 30 | 3 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 198 | 30 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 30 | 3 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-04 | 198 | 30 | 3 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 198 | 30 | 3 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.12e-04 | 198 | 30 | 3 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | mild|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.12e-04 | 198 | 30 | 3 | 3cef2e13d5ec71bb265171239980697a2560fa30 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 198 | 30 | 3 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 198 | 30 | 3 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 198 | 30 | 3 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.12e-04 | 198 | 30 | 3 | 2cd13418396ab2c53b1be96e7795841c2482bfca | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.17e-04 | 199 | 30 | 3 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 199 | 30 | 3 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | distal-mesenchymal-Myofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.17e-04 | 199 | 30 | 3 | 79917b5225cb45b4a0ea937f79f1752346e4346e | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.17e-04 | 199 | 30 | 3 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-04 | 200 | 30 | 3 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-04 | 200 | 30 | 3 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-04 | 200 | 30 | 3 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.08e-03 | 101 | 30 | 2 | cf52c93f523c5f25bd45519a1444ce7bd1d8b577 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Tacr3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.42e-03 | 109 | 30 | 2 | 92ab514fd8d6711f55de9671fc80da22b20ad248 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-03 | 110 | 30 | 2 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-03 | 117 | 30 | 2 | f3c77b234e461566aac81ede0ef84008c9a9f51e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.02e-03 | 122 | 30 | 2 | 37612ad087d9c11d4a3466244ab36224de31930b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.22e-03 | 126 | 30 | 2 | 84dce108561d4b745d19250c2ac0667d9e4ea17d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.22e-03 | 126 | 30 | 2 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.37e-03 | 129 | 30 | 2 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.47e-03 | 131 | 30 | 2 | d76a7a9b50ee6d24b74494c6f6b88b3506b3f9ad | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-03 | 133 | 30 | 2 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.57e-03 | 133 | 30 | 2 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-03 | 133 | 30 | 2 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.63e-03 | 134 | 30 | 2 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.52e-07 | 196 | 29 | 6 | 4331_UP | |
| Drug | AC1LAKND | 1.12e-06 | 62 | 29 | 4 | CID000470146 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.77e-06 | 162 | 29 | 5 | 2658_UP | |
| Drug | BAPN | 1.94e-06 | 71 | 29 | 4 | CID000001647 | |
| Drug | L-3,4-dehydroproline | 2.17e-06 | 73 | 29 | 4 | CID000094284 | |
| Drug | khellin | 2.31e-06 | 171 | 29 | 5 | CID000003828 | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.31e-06 | 171 | 29 | 5 | 3297_UP | |
| Drug | halofuginone lactate | 4.00e-06 | 85 | 29 | 4 | CID000062891 | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A | 4.29e-06 | 194 | 29 | 5 | 6756_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; HL60; HG-U133A | 4.29e-06 | 194 | 29 | 5 | 1396_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 4.51e-06 | 196 | 29 | 5 | 1666_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.51e-06 | 196 | 29 | 5 | 2262_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 4.74e-06 | 198 | 29 | 5 | 2088_UP | |
| Drug | 4-hydroxyproline | 5.25e-06 | 91 | 29 | 4 | CID000000825 | |
| Drug | ticlopidine | 8.60e-06 | 103 | 29 | 4 | CID000005472 | |
| Drug | Collagenase | 9.38e-06 | 4 | 29 | 2 | DB00048 | |
| Drug | isodesmosine | 9.88e-06 | 33 | 29 | 3 | CID000013811 | |
| Drug | hydroxylysine | 1.08e-05 | 109 | 29 | 4 | CID000001029 | |
| Drug | GK-101 | 1.29e-05 | 36 | 29 | 3 | CID000161853 | |
| Drug | Tranilast sodium | 1.33e-05 | 115 | 29 | 4 | CID000005527 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.56e-05 | 5 | 29 | 2 | ctd:C575894 | |
| Drug | BPAT-143 | 2.34e-05 | 6 | 29 | 2 | CID000146249 | |
| Drug | Madecassol | 2.72e-05 | 46 | 29 | 3 | CID000108062 | |
| Drug | pirfenidone | 2.73e-05 | 138 | 29 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 2.81e-05 | 139 | 29 | 4 | CID000004727 | |
| Drug | PCR 4099 | 2.81e-05 | 139 | 29 | 4 | CID000002806 | |
| Drug | d-indobufen | 3.50e-05 | 50 | 29 | 3 | CID000044562 | |
| Drug | ridogrel | 3.94e-05 | 52 | 29 | 3 | CID005362391 | |
| Drug | desmosine | 4.17e-05 | 53 | 29 | 3 | CID000025435 | |
| Drug | NSC49633 | 4.17e-05 | 53 | 29 | 3 | CID000023340 | |
| Drug | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 5.44e-05 | 545 | 29 | 6 | ctd:C049584 | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 5.48e-05 | 165 | 29 | 4 | 3770_UP | |
| Drug | P-N-C | 5.76e-05 | 59 | 29 | 3 | CID000449243 | |
| Drug | AC1L1DD6 | 7.52e-05 | 179 | 29 | 4 | CID000002299 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.69e-05 | 180 | 29 | 4 | 6886_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 7.69e-05 | 180 | 29 | 4 | 4541_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.86e-05 | 181 | 29 | 4 | 6951_DN | |
| Drug | 4-aminoazobenzene | 8.05e-05 | 66 | 29 | 3 | CID000006051 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 8.20e-05 | 183 | 29 | 4 | 1206_UP | |
| Drug | Alsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A | 9.10e-05 | 188 | 29 | 4 | 7056_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 9.48e-05 | 190 | 29 | 4 | 3733_UP | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.87e-05 | 192 | 29 | 4 | 3753_DN | |
| Drug | malotilate | 1.00e-04 | 71 | 29 | 3 | CID000004006 | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.01e-04 | 193 | 29 | 4 | 4289_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.01e-04 | 193 | 29 | 4 | 3811_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 4952_DN | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 5051_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 6763_DN | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 5330_DN | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 6834_UP | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 1512_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 7092_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 4101_DN | |
| Drug | clozapine; Down 200; 10uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 4453_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 4720_UP | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 3985_DN | |
| Drug | LY294002; Up 200; 0.1uM; MCF7; HG-U133A | 1.07e-04 | 196 | 29 | 4 | 424_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3797_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3404_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 5276_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 2698_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 6229_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3769_DN | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 1824_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 4299_UP | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 2529_DN | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5798_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 4681_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6550_UP | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 2625_DN | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 2157_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 2449_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; HL60; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 2567_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 3354_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 2063_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 6628_DN | |
| Drug | AC1NMZ1B | 1.18e-04 | 75 | 29 | 3 | CID005034185 | |
| Drug | strontium ranelate | 1.28e-04 | 77 | 29 | 3 | CID006918182 | |
| Drug | 1zp8 | 1.28e-04 | 77 | 29 | 3 | CID004369521 | |
| Drug | ascorbate-2-phosphate | 1.63e-04 | 15 | 29 | 2 | ctd:C011669 | |
| Drug | AC1Q6PCP | 1.98e-04 | 230 | 29 | 4 | CID000005267 | |
| Drug | 4,4'-DBP | 2.64e-04 | 19 | 29 | 2 | CID000007034 | |
| Drug | pyridinoline | 2.68e-04 | 99 | 29 | 3 | CID000105068 | |
| Drug | 351A | 2.93e-04 | 20 | 29 | 2 | CID000122144 | |
| Drug | Glucose | 2.96e-04 | 1420 | 29 | 8 | ctd:D005947 | |
| Drug | hyaluronan | 3.29e-04 | 263 | 29 | 4 | CID000024759 | |
| Drug | AC1L1C2F | 3.66e-04 | 110 | 29 | 3 | CID000001711 | |
| Drug | methanethiol | 3.86e-04 | 112 | 29 | 3 | CID000000878 | |
| Drug | PPACK | 3.96e-04 | 113 | 29 | 3 | CID003036757 | |
| Drug | AC1L9732 | 4.06e-04 | 114 | 29 | 3 | CID000439300 | |
| Drug | silibinin | 4.46e-04 | 285 | 29 | 4 | CID000005213 | |
| Drug | Thiram | 5.15e-04 | 533 | 29 | 5 | ctd:D013893 | |
| Drug | Selara | 5.32e-04 | 125 | 29 | 3 | CID000150310 | |
| Drug | AP-5 | 5.70e-04 | 128 | 29 | 3 | CID000001216 | |
| Drug | AC1L3V67 | 5.80e-04 | 28 | 29 | 2 | CID000147439 | |
| Drug | 2,3-pentanedione | 5.83e-04 | 129 | 29 | 3 | ctd:C013186 | |
| Drug | AC1OCADI | 5.96e-04 | 130 | 29 | 3 | CID006914639 | |
| Drug | Curcumin | 6.05e-04 | 850 | 29 | 6 | ctd:D003474 | |
| Drug | DMSe | 6.23e-04 | 132 | 29 | 3 | CID000020796 | |
| Drug | ptaquiloside | 6.37e-04 | 133 | 29 | 3 | ctd:C043680 | |
| Disease | Menke-Hennekam syndrome | 9.33e-07 | 2 | 29 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 9.33e-07 | 2 | 29 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 9.33e-07 | 2 | 29 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.33e-07 | 2 | 29 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.33e-07 | 2 | 29 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 9.33e-07 | 2 | 29 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 9.33e-07 | 2 | 29 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 9.33e-07 | 2 | 29 | 2 | C0035934 | |
| Disease | Small cell carcinoma of lung | 2.05e-05 | 54 | 29 | 3 | C0149925 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 3.34e-05 | 9 | 29 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 1.11e-04 | 95 | 29 | 3 | C0279626 | |
| Disease | Leukemia, Myelocytic, Acute | 6.47e-04 | 173 | 29 | 3 | C0023467 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.47e-04 | 41 | 29 | 2 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 7.47e-04 | 41 | 29 | 2 | C0007138 | |
| Disease | Breast adenocarcinoma | 7.47e-04 | 41 | 29 | 2 | C0858252 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.15e-04 | 195 | 29 | 3 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPQPIPGQPGMPQGQ | 2096 | Q09472 | |
| QPPPRGGTRGQEPQM | 31 | P20290 | |
| FQQPQGPGGYPPAMQ | 2231 | Q92793 | |
| FPGGQMPSQYPGGQP | 126 | P20073 | |
| GPQGARGQPGVMGFP | 591 | P02458 | |
| PYGQQVGVLGPPGQQ | 1556 | Q86U86 | |
| GYTPPGAGNQNPPGM | 331 | Q93052 | |
| QRGMGGQQAPPGLGP | 556 | Q71SY5 | |
| PVGPMGVNANPFPRG | 351 | P0CG12 | |
| GNNGAQGPPGPQGVQ | 526 | P08123 | |
| GGPQQQGYMPLEGPQ | 401 | Q5SW24 | |
| SPGMPGQPEQRGGPQ | 71 | Q9Y5R5 | |
| PPGPPGIPFNERNGM | 811 | Q14993 | |
| PQGRMGFPQGFPPVQ | 1131 | O00512 | |
| VQDPMQLRGGPPFPG | 586 | Q86UU0 | |
| QAPNFMPGPRGIQPQ | 1951 | Q9BTC0 | |
| GQQGNPGAQGLPGPQ | 721 | P20908 | |
| PQAPFGFPGDGMQQP | 316 | O95104 | |
| QVPLPPNGQMPGFGL | 356 | O95104 | |
| PRGRPQGPPQQGGHQ | 121 | P02810 | |
| PAGPMGPFNPGPFNQ | 511 | Q92945 | |
| QRPPPQGGPGQPQGM | 451 | Q92777 | |
| GPGMAAPPRQQQGPG | 11 | Q13033 | |
| MGNQPPGGVPGTQPL | 166 | Q9BWW4 | |
| GQPQSVPPPQMGGSG | 476 | O75157 | |
| QRPSGPGPMNQGPQQ | 721 | Q92540 | |
| PNRGGAPGAPQGDPM | 301 | Q9BY78 | |
| NQNRGPMGPGPGQSG | 41 | P23246 | |
| QQQGYGPSQGGPGPQ | 361 | Q15532 | |
| QAPIGNPPVGPIGGM | 391 | O43670 | |
| QPFPGQGPMSQIPQG | 586 | Q9C0J8 | |
| QMGPPGPQGQFRPPG | 616 | Q9C0J8 | |
| GPQGQFRPPGPQGQM | 621 | Q9C0J8 | |
| FRPPGPQGQMGPQGP | 626 | Q9C0J8 | |
| PQGQMGPQGPPLHQG | 631 | Q9C0J8 | |
| GFMGPQGPQGPPQGL | 651 | Q9C0J8 | |
| PRGMQGPPGPRENQG | 781 | Q9C0J8 | |
| GMQGPPGPQGQQNPA | 876 | Q9C0J8 | |
| PQGQQQPGPGQQLGG | 6 | Q7Z7E8 |